3 ms·
It is a concern, look at the current monoclonal antibody alzheimer's treatment that's insanely expensive. Generally though it's in the interest of the rich to
by RobotToaster 3y ago
It is a concern, look at the current monoclonal antibody alzheimer's treatment that's insanely expensive.
Generally though it's in the interest of the rich to extend the useful lifespan of their workers, training workers from babies is expensive, so it could be cheaper to keep the current ones going for 200 years.
- BizarreByte 3y ago> so it could be cheaper to keep the current ones going for 200 years. This sounds like a form of hell. I'd rather die than work for 200 years, I can already barely stomach working as long as I have to.
- justrealist 3y agoUnemployment is record low. You could get practically any job you want right now. Why are you working a job you hate?
- insanitybit 3y agoYou're picking one single treatment and saying "look, this is proof of the problem", ignoring that the treatment is extremely new - like, ~2 years of availability (and it was rushed out!). There may be inherent costs to the treatment that are specific and unrelated to whatever is found in other treatments.